Key Highlights
- 6.5% above its 52-week low is where Healthcare Realty Trust (NYSE:HR) traded at USD 17.38 on October 16, 2026, per published market data (intraday). The implied low is USD 16.32, own arithmetic; the exact low price was not independently confirmed.
- USD 1.64 is the midpoint of raised 2026 normalized FFO guidance of USD 1.62 to USD 1.66 per share, up from USD 1.59 to USD 1.65, per the release dated July 30, 2026. That equals 10.6 times the current price, own arithmetic.
- 5.6x run-rate net debt to adjusted EBITDA was reported at June 30, 2026, with approximately USD 1.6 billion of liquidity as stated by the company. Second-quarter normalized FFO was USD 0.41 per share, unchanged from the prior-year quarter.
- USD 0.24 is the quarterly dividend, or USD 0.96 annualized: a 5.5% yield on USD 17.38 and 58.5% of the normalized FFO guidance midpoint, own arithmetic on declared and guided figures. Distributions are not guaranteed.
Price Action and Catalyst Review
Healthcare Realty Trust (NYSE:HR) rose 0.03% to USD 17.38 on October 16, 2026, per published market data (intraday). The stock gapped up 0.46% and then traded 0.49% below the open, so early buying faded and the gap was erased. Volume was 228,314 shares at 0.1x relative volume, giving turnover of USD 3.97 million (own arithmetic), 0.07% of the USD 5.95 billion market capitalization. RSI was 38.0, below the neutral 50 line. No company-specific catalyst was identified in the filings and releases reviewed through October 16, 2026.
Earnings, Leverage and Capital Allocation
Second-quarter results on July 30, 2026 were stable but not accelerating. NAREIT FFO was USD 0.36 against USD 0.34, normalized FFO held at USD 0.41, same-store cash NOI grew 5.1%, and tenant retention was 88.5%. Guidance for same-store cash NOI rose to 4.25% to 5.00% from 3.75% to 4.75%. The company issued USD 700 million of 3.00% exchangeable senior notes due 2032, mostly to repay USD 600 million of notes due 2026, and repurchased 3.8 million shares for USD 75 million, or USD 19.74 per share (own arithmetic).
Valuation, Risks and Monitoring Points
Dispositions of USD 83 million at a sub-5% cap rate, against joint venture acquisitions at a blended cash yield of 7.5%, imply private buyers value medical office assets above the 9.4% normalized FFO yield the stock offers (own arithmetic). The bear case is 5.6x leverage with a 10-year Treasury yield at 5.09%, flat quarterly normalized FFO, and no portfolio-wide occupancy figure in the release reviewed. The exchangeable notes may dilute holders if converted. Third-quarter results and the next dividend declaration are not yet dated in the materials reviewed.
Where Things Stand
Healthcare Realty Trust (NYSE:HR) trades 6.5% above its 52-week low because investors are pricing leverage of 5.6x, flat quarterly normalized FFO and a 5.09% Treasury yield, despite raised guidance. The evidence is balanced: guidance and same-store cash NOI growth moved higher, dispositions cleared at a sub-5% cap rate, and the dividend equals 58.5% of the guidance midpoint. Against that, USD 0.41 of normalized FFO was unchanged year on year, and a 10.6 times multiple signals doubt over durability. The next catalysts are third-quarter results and any dividend declaration, neither dated in the materials reviewed, plus further disposition closings by year end.





_11_20_2026_12_38_15_908731.jpg)
Please wait processing your request...